Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

Dec. 10, 1997

StressGen prepares to evaluate Oncocine in clinical trials

Dec. 9, 1997

Seragen submits BLA for CTCL biological product

Dec. 9, 1997

IL-12 for treatment of malignant tumors

Dec. 8, 1997

OncoVax-P clinical data reported at scientific meeting

Dec. 5, 1997

Maxim reports promising data from AML trial with Maxamine

Dec. 4, 1997

Virulizin interim phase I/II results in advanced pancreatic cancer

Dec. 2, 1997

Rituximab launched in Switzerland

Nov. 28, 1997

First anticancer monoclonal antibody approved by FDA

Nov. 27, 1997

Results from Leuvectin trial in kidney cancer patients reported

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...